These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5854786)

  • 1. [Use and activity of rifomycin in local treatment of extrapulmonary tubercular forms].
    Zanotelli F
    Fracastoro; 1965; 58(5):353-61. PubMed ID: 5854786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Local therapeutic trials of various forms of extrapulmonary tuberculosis using rifampicin suspension].
    Basacopol A; Burzoni FJ; Munteanu E
    Maroc Med; 1974 May; 54(579):314-6. PubMed ID: 4444315
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous use of rifampicin.
    Nilsson BS; Boman G
    Eur J Respir Dis; 1981 Jun; 62(3):212-4. PubMed ID: 7308336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experimentation with rifomycin in dermatologic and venereal diseases].
    Rasponi L
    G Clin Med; 1969 Oct; 50(10):896-903. PubMed ID: 5386614
    [No Abstract]   [Full Text] [Related]  

  • 5. [Abbreviated treatment of tuberculosis. Experience in large cities].
    Yañez A; Valenzuela P
    Bol Oficina Sanit Panam; 1982 Feb; 92(2):127-42. PubMed ID: 6462154
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution to the use of rifomycin SV (rifocin) in the treatment of tuberculosis].
    Havel A; Tousek J; Trnka L
    Prax Pneumol; 1967 May; 21(5):284-92. PubMed ID: 5600336
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis.
    Ruslami R; Nijland H; Aarnoutse R; Alisjahbana B; Soeroto AY; Ewalds S; van Crevel R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):822-3. PubMed ID: 16436757
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parenteral rifomycin SV in treatment of advanced chronic pulmonary tuberculosis].
    Rey JC; Leston JM; Gonzalez Montaner LJ; Fernandez JM; Szemzo J; Martini MA
    G Ital Tuberc Mal Torace; 1965; 19(4):96-104. PubMed ID: 5846582
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relapse in tuberculosis].
    Kameda K
    Kekkaku; 1983 Feb; 58(2):73-80. PubMed ID: 6855045
    [No Abstract]   [Full Text] [Related]  

  • 11. [Compliance, efficacy and tolerability of the therapeutic regimen recommended by National Consensus on Tuberculosis].
    Colmenero JD; García-Ordoñez MA; Sebastián MD; Pérez-Ruiz E; Sánchez-Lora J; Sánchez-González J; Bentabol G; Juárez C
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):129-33. PubMed ID: 9235051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limitations of long-term treatment with rifampicin infusion in tubercular disease].
    Rosetti L; Serra A; Arba GV
    G Ital Chemioter; 1982; 29(2):125-32. PubMed ID: 7186465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of rifomycin on the dynamics of experimentally induced tuberculous lesions].
    Diaconitza G; Eskenasy A
    Acta Tuberc Pneumol Belg; 1971; 62(1):62-81. PubMed ID: 5568579
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tuberculosis in hemodialysis].
    Zahiri K; Ramdani B; Hachim K; Benghanem MG; Fatihi E; Zaid D
    Nephrologie; 1997; 18(7):303-6. PubMed ID: 9496572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of pulmonary tuberculosis of native Black Africans a chemotherapeutic regime including rifampicin (apropos of 75 patients)].
    Ayad M; Hane A; Kane PA
    Dakar Med; 1980; 25(1):65-74. PubMed ID: 7460740
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifomycin in local treatments of tuberculosis].
    Dumon G; Taranger J; Dumon-Legré M; Brouillet-Gabriel MT
    Mars Med; 1966; 103(11):839-43. PubMed ID: 5991816
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifapentine--a long-acting rifamycin for tuberculosis.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):21-2. PubMed ID: 10076594
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of plasma levels of rifomycin and their variations (440 analyses)].
    Constans P; Saint-Paul M; Morin Y; Bonnaud G; Bariety M
    Acta Tuberc Pneumol Belg; 1969; 60(3):299-314. PubMed ID: 5371666
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.
    Losso MH; Lourtau LD; Toibaro JJ; Saenz C; González C
    Antivir Ther; 2004 Dec; 9(6):1031-3. PubMed ID: 15651762
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the use of Rifampicinin dermatovenereology].
    Bonu G; Bechini E; De Santolo GP
    Minerva Med; 1969 Dec; 60(96):4840-4. PubMed ID: 5395261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.